In conclusion, this study showed that in our population of Asian glaucoma patients undergoing trabeculectomy and phaco-trabeculectomy, 2 weeks of therapy comprising FML eyedrops pre-operatively improved early trabeculectomy outcomes for those with higher pre-operative MCP-1 levels, with a reduction in the odds of requiring rescue interventions for impending bleb failure. Here, CCL2 is linked to glaucoma.